GENEVA--(BUSINESS WIRE)--Sept. 15, 2006--Molecular Vision Ltd in partnership with Acrongenomics, Inc. (OTCBB:AGNM - News), Pearson Matthews Ltd, and Imperial College London has today been awarded GBP 440,000 (US $825,000) by the UK Government's Health Technology Devices (HTD) Scheme for the development of a line of low cost, easy-to-use and portable point-of-care diagnostic devices for testing of cardiovascular health. The HTD scheme, which provides 50% funding, aims to stimulate new and innovative health care technologies designed to improve significantly the quality of healthcare in the United Kingdom.
